Voyager Therapeutics (VYGR) Cash from Operations (2014 - 2026)
Voyager Therapeutics recorded quarterly Cash from Operations of 33419000.0 in Q1 2026, down 10.43% quarter-over-quarter from 30263000.0 in Q4 2025, and up 11.81% year-over-year from 29888673.98 in Q1 2025.
Voyager Therapeutics' Cash from Operations history runs 13 years deep, the most recent figure standing at 33419000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 11.81% year-over-year to 33419000.0; the TTM figure through Mar 2026 stood at 127991000.0 (down 14.31% YoY), while the FY2025 annual figure was 132467000.0, down 765.23% from the prior year.
- Cash from Operations came in at 33419000.0 for Q1 2026 at Voyager Therapeutics, down from 30263000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 123565000.0 in Q1 2023 to a low of 37895000.0 in Q1 2025.
- A 5-year average of 6810941.18 and a median of 21051000.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations surged 261.67% in 2022 and slumped 3682.04% in 2024, its largest moves.
- Voyager Therapeutics' Cash from Operations stood at 12244000.0 in 2022, then plunged by 94.05% to 23760000.0 in 2023, then surged by 38.85% to 14529000.0 in 2024, then sank by 108.29% to 30263000.0 in 2025, then fell by 10.43% to 33419000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 33419000.0, 30263000.0, and 31048000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - | -33.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.42 Mn |
| Mar 31, 2026 | -33.42 Mn |
| Dec 31, 2025 | -30.26 Mn |
| Dec 31, 2025 | -30.26 Mn |
| Sep 30, 2025 | -31.05 Mn |
| Sep 30, 2025 | -31.05 Mn |
| Jun 30, 2025 | -33.26 Mn |
| Jun 30, 2025 | -33.26 Mn |
| Mar 31, 2025 | -37.90 Mn |
| Mar 31, 2025 | -37.90 Mn |
| Dec 31, 2024 | -14.53 Mn |
| Dec 31, 2024 | -14.53 Mn |
| Sep 30, 2024 | -27.97 Mn |
| Sep 30, 2024 | -27.97 Mn |
| Jun 30, 2024 | -31.58 Mn |
| Jun 30, 2024 | -31.58 Mn |
| Mar 31, 2024 | 58.77 Mn |
| Mar 31, 2024 | 58.77 Mn |
| Dec 31, 2023 | -23.76 Mn |
| Dec 31, 2023 | -23.76 Mn |
| Sep 30, 2023 | -21.05 Mn |
| Sep 30, 2023 | -21.05 Mn |
| Jun 30, 2023 | -835,000.00 |
| Jun 30, 2023 | -835,000.00 |
| Mar 31, 2023 | 123.57 Mn |
| Mar 31, 2023 | 123.57 Mn |
| Dec 31, 2022 | -12.24 Mn |
| Dec 31, 2022 | -12.24 Mn |
| Sep 30, 2022 | -16.21 Mn |
| Sep 30, 2022 | -16.21 Mn |
| Jun 30, 2022 | -18.49 Mn |
| Jun 30, 2022 | -18.49 Mn |
| Mar 31, 2022 | 34.43 Mn |
| Mar 31, 2022 | 34.43 Mn |
| Dec 31, 2021 | 11.20 Mn |
| Dec 31, 2021 | 11.20 Mn |
| Sep 30, 2021 | -20.71 Mn |
| Sep 30, 2021 | -20.71 Mn |
| Jun 30, 2021 | -22.72 Mn |
| Jun 30, 2021 | -22.72 Mn |
| Mar 31, 2021 | -21.29 Mn |
| Mar 31, 2021 | -21.29 Mn |
| Dec 31, 2020 | -21.98 Mn |
| Dec 31, 2020 | -21.98 Mn |
| Sep 30, 2020 | -24.74 Mn |
| Sep 30, 2020 | -24.74 Mn |
| Jun 30, 2020 | -21.20 Mn |
| Jun 30, 2020 | -21.20 Mn |
| Mar 31, 2020 | -28.80 Mn |
| Mar 31, 2020 | -28.80 Mn |
| Dec 31, 2019 | -23.36 Mn |
| Dec 31, 2019 | -23.36 Mn |
| Sep 30, 2019 | -21.58 Mn |
| Sep 30, 2019 | -21.58 Mn |
| Jun 30, 2019 | -31.56 Mn |
| Jun 30, 2019 | -31.56 Mn |
| Mar 31, 2019 | 125.16 Mn |
| Mar 31, 2019 | 125.16 Mn |
| Dec 31, 2018 | -24.35 Mn |
| Dec 31, 2018 | -24.35 Mn |
| Sep 30, 2018 | -17.65 Mn |
| Sep 30, 2018 | -17.65 Mn |
| Jun 30, 2018 | -22.50 Mn |
| Jun 30, 2018 | -22.50 Mn |
| Mar 31, 2018 | 48.61 Mn |
| Mar 31, 2018 | 48.61 Mn |
| Dec 31, 2017 | -14.83 Mn |
| Dec 31, 2017 | -14.83 Mn |
| Sep 30, 2017 | -15.89 Mn |
| Sep 30, 2017 | -15.89 Mn |
| Jun 30, 2017 | -16.34 Mn |
| Jun 30, 2017 | -16.34 Mn |
| Mar 31, 2017 | -14.29 Mn |
| Mar 31, 2017 | -14.29 Mn |
| Dec 31, 2016 | -13.09 Mn |
| Dec 31, 2016 | -13.09 Mn |
| Sep 30, 2016 | -10.19 Mn |
| Sep 30, 2016 | -10.19 Mn |
| Jun 30, 2016 | -9.71 Mn |
| Jun 30, 2016 | -9.71 Mn |
| Mar 31, 2016 | -9.49 Mn |
| Mar 31, 2016 | -9.49 Mn |
| Dec 31, 2015 | -9.56 Mn |
| Dec 31, 2015 | -9.56 Mn |
| Sep 30, 2015 | -6.75 Mn |
| Sep 30, 2015 | -6.75 Mn |
| Jun 30, 2015 | -6.98 Mn |
| Jun 30, 2015 | -6.98 Mn |
| Mar 31, 2015 | 64.59 Mn |
| Mar 31, 2015 | 64.59 Mn |
| Dec 31, 2014 | -4.79 Mn |
| Dec 31, 2014 | -4.79 Mn |